Aspirin Sustained-Release Capsules Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

Name	Aspirin Sustained-Release Capsules
Trade name	Durlaza
Specifications	162.5mg
Dosage form	Capsules (sustained release capsules)
Licensee	New Haven Pharmaceuticals Inc
Remarks	American Orange Book

This product is used to prevent the second attack after the first cardiac and cerebrovascular event, including:-myocardial infarction-stable and unstable angina pectoris-coronary angioplasty-transient ischemic attack (TIA) )-Non-hemorrhagic stroke-Prevention of embolism after coronary artery bypass surgery. For those who need rapid onset (such as acute myocardial ischemia or unstable angina), this product should not be used.

Hot Tags: Aspirin Sustained-Release Capsules Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Argatroban Injection, Acarbose Tablets, Adefovir Dipivoxil Tablets, Alfacalcidol Soft Capsules, Olanzapine Tablets, Reference Listed Drugs

• Previous: Amoxicillin Chewable Tablets Reference Listed Drug
• Next: Ibuprofen Orally Disintegrating Tablets Reference Listed Drug